Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,548.63
(
-0.66%
)
US TECH 100
23,260.40
(
-1.07%
)
Dow Jones
46,349.09
(
-0.17%
)
Brent Oil
101.87
(
3.13%
)
Bitcoin
69,368.90
(
-2.71%
)
News Focus
News Focus
Post# of 648882
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Tuff-Stuff

Send PM Follow Ignore
Followers 217
Posts 247348
Boards Moderated 2
Alias Born 04/06/2006

Tuff-Stuff

Re: Tuff-Stuff post# 321245

Friday, 05/28/2010 9:29:34 AM

Friday, May 28, 2010 9:29:34 AM

Post# of 648882
Amgen's (AMGN) new drug Prolia for treatment of osteoporosis wins approval for sale in Europe. GlaxoSmithKline (GSK) will market the drug, throwing its weight behind a product that industry analysts expect to make billions of dollars in annual sales. AMGN +1%, GSK +1.7% premarket.

Your World Is As BIG as You Make It!!!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today